thalidomide has been researched along with Intracranial Arteriovenous Malformations in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Intracranial Arteriovenous Malformations: Congenital vascular anomalies in the brain characterized by direct communication between an artery and a vein without passing through the CAPILLARIES. The locations and size of the shunts determine the symptoms including HEADACHES; SEIZURES; STROKE; INTRACRANIAL HEMORRHAGES; mass effect; and vascular steal effect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nip, L | 1 |
| Evans, N | 1 |
| Bali, S | 1 |
| Hopper, C | 1 |
| Papadopoulou, A | 1 |
| Khalifa, M | 1 |
| Hamilton, G | 1 |
| Lim, CS | 1 |
| Brookes, J | 1 |
| Zhu, W | 1 |
| Chen, W | 1 |
| Zou, D | 1 |
| Wang, L | 1 |
| Bao, C | 1 |
| Zhan, L | 1 |
| Saw, D | 1 |
| Wang, S | 1 |
| Winkler, E | 1 |
| Li, Z | 1 |
| Zhang, M | 1 |
| Shen, F | 1 |
| Shaligram, S | 1 |
| Lawton, M | 1 |
| Su, H | 1 |
2 other studies available for thalidomide and Intracranial Arteriovenous Malformations
| Article | Year |
|---|---|
Early experience of thalidomide therapy for high-grade peripheral and facial arteriovenous malformations.
Topics: Embolization, Therapeutic; Humans; Intracranial Arteriovenous Malformations; Radiosurgery; Retrospec | 2023 |
Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Angiogenesis Inhibitors; Animals; Blood Vesse | 2018 |